Hasin DS, Goodwin RD, Stinson FS, et al. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62:1097-1106. Abstract
Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-627. Abstract
Nimalasuriya K, Compton MT, Guillory VJ; Prevention Practice Committee of the American College of Preventive Medicine. Screening adults for depression in primary care: a position statement of the American College of Preventive Medicine. J Fam Pract. 2009;58:535-538. Abstract
Löwe B, Spitzer R, Gräfe K, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord. 2004;78:131-140. Abstract
O'Connor EA, Whitlock EP, Beil TL, Gaynes BN. Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med. 2009;151:793-803. Abstract
American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, Third Edition (2010). Available at: http://www.psychiatryonline.com/pracGuide/pracGuideTopic_7.aspx Accessed October 1, 2010.
AMA-PCPI Physician Consortium for Performance Improvement^® (PCPI). Adult Major Depressive Disorder: Physician Performance Measurement Set. 2006; updated 2010. Available at: http://www.ama-assn.org/ama1/pub/upload/mm/370/major-depressive-disorder-adult-worksheets.pdf. Accessed October 18, 2010.
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282:1737-1744. Abstract
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613.
Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinical rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54:573-583. Abstract
Nock MK, Borges G, Bromet EJ, et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry. 2008;192:98-105. Abstract
Nock MK, Borges G, Bromet EJ, et al. Suicide and suicidal behavior. Epidemiol Rev. 2008;30:133-154. Abstract
Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System (WISQARS). Available at: http://www.cdc.gov/injury/wisqars/index.html Accessed October 18, 2010.
American Foundation for Suicide Prevention. Facts and figures. Available at: http://www.afsp.org/index.cfm?fuseaction=home.viewpage&page_id=050fea9f-b064-4092-b1135c3a70de1fda Accessed December 2, 2010.
Valente SM. Assessing patients for suicide risk. Nursing. 2010;40:36-40.
Borges G, Nock MK, Haro Aba JM, et al. Twelve-month prevalence of and risk factors for suicide attempts in the world health organization mental health surveys. J Clin Psychiatry. 2010 [Epub ahead of print].
National Guideline Clearinghouse. Agency for Healthcare Research and Quality (AHRQ). Major depression in adults in primary care. Available at: http://www.guideline.gov/content.aspx?id=14857&search-Suicide+risk+assessment Accessed October 18, 2010.
Schulberg HC, Bruce ML, Lee PW, Williams JW Jr, Dietrich AJ. Preventing suicide in primary care patients: the primary care physician's role. Gen Hosp Psychiatry. 2004;26:337-345. Abstract
Meyer RE, Salzman C, Youngstrom EA, et al. Suicidality and risk of suicide -- definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry. 2010;71:e1-e21. Abstract
Meyer RE, Salzman C, Youngstrom EA, et al. Suicidality and risk of suicide -- definition, drug safety concerns, and a necessary target for drug development: a brief report. J Clin Psychiatry. 2010;71:1040-1046. Abstract
Witte TK, Gould MS, Munfakh JL, Kleinman M, Joiner TE Jr, Kalafat J. Assessing suicide risk among callers to crisis hotlines: a confirmatory factor analysis. J Clin Psychol. 2010;66:941-964. Abstract
Risk Management Foundation of the Harvard Medical Institutions, Inc. Guidelines for identification, assessment, and treatment planning for suicidality. 1996. Available at: http://www.rmf.harvard.edu/files/documents/suicideAs.pdf Accessed September 29, 2010.
Peruzzi N, Bongar B. Assessing risk for completed suicide in patients with major depression: psychologists' view of critical factors. Prof Psychol Res Pract. 1999;30:576-580.
Taylor A, Dal Grande E, Gill T, et al. Detecting determinants of suicidal ideation: South Australian surveillance system results. Int J Public Health. 2007;52:142-152. Abstract
Claassen CA, Trivedi MH, Rush AJ, et al. Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial. J Affect Disord. 2007;97:77-84. Abstract
Weinstock R, Vari G, Leong GB, Silva JA. Back to the past in California: a temporary retreat to a Tarasoff duty to warn. J Am Acad Psychiatry Law 2006;34:523-528.
California Supreme Court. Tarasoff v. Regents of the University of California. Wests Calif Report. 1974;118:129-145. Available at: http://www.publichealthlaw.net/Reader/docs/Tarasoff.pdf#search=%22Tarasoff%20v.%20Regents%20of%20the%20University%20of%20California%22 Accessed November 22, 2010.
4therapy.com. Duty to Protect. Available at: http://www.4therapy.com/professional/research/lawandethics/item.php?uniqueid=4612&categoryid=271& Accessed September 27, 2010.
Chaimowitz GA, Glancy GD, Blackburn J. The duty to warn and protect -- impact on practice. Can J Psychiatry. 2000;45:899-904. Abstract
Scarano VR, Baily CM, Banfield JR. The Texas Supreme Court speaks: mental health professionals have no duty to warn or protect third parties. Tex Med. 2002;98:61-64. Abstract
Kachigian C, Felthous AR. Court responses to Tarasoff statutes. J Am Acad Psychiatry Law. 2004;32:263-273. Abstract
Mermelstein HT, Wallack JJ. Confidentiality in the age of HIPAA: a challenge for psychosomatic medicine. Psychosomatics. 2008;49:97-103. Abstract
Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: a systematic review. JAMA. 2005;294:2064-2074. Abstract
Luoma JB, Martin CE, Pearson JL. Contact with mental health and primary care providers before suicide: a review of the evidence. Am J Psychiatry. 2002;159:909-916. Abstract
Pirkis J, Burgess P. Suicide and recency of health care contacts. A systematic review. Br J Psychiatry. 1998;173:462-474. Abstract
Carney SS, Rich CL, Burke PA, Fowler RC. Suicide over 60: the San Diego study. J Am Geriatr Soc. 1994;42:174-180. Abstract
Palmieri G, Forghieri M, Ferrari S, et al. Suicide intervention skills in health professionals: a multidisciplinary comparison. Arch Suicide Res. 2008;12:232-237. Abstract
Feldman MD, Franks P, Duberstein PR, Vannoy S, Epstein R, Kravitz RL. Let's not talk about it: suicide inquiry in primary care. Ann Fam Med. 2007;5:412-418. Abstract
Vannoy SD, Fancher T, Meltvedt C, Unutzer J, Duberstein P, Kravitz RL. Suicide inquiry in primary care: creating context, inquiring, and following up. Ann Fam Med. 2010;8:33-39. Abstract
Posner K, Oquendo MA, Gould M, Stanley B, Dvies M. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007;164:1035-1043. Abstract
Shea SC. The chronological assessment of suicide events: a practical interviewing strategy for the elicitation of suicidal ideation. For the Training Institute for Suicide Assessment and Clinical Interviewing (TISA). Available at: http://suicideassessment.com Accessed September 29, 2010.
Rudd MD. Suicide warning signs in clinical practice. Curr Psychiatry Rep. 2008;10:87-90. Abstract
Oordt MS, Jobes DA, Fonseca VP, Schmidt SM. Training mental health professionals to assess and manage suicidal behavior: can provider confidence and practice behaviors be altered? Suicide Life Threat Behav. 2009;39:21-32.
McNiel DE, Fordwood SR, Weaver CM, Chamberlain JR, Hall SE, Binder RL. Effects of training on suicide risk assessment. Psychiatr Serv. 2008;59:1462-1465. Abstract
Friedman RA, Leon AC. Expanding the black box -- depression, antidepressants, and the risk of suicide. N Engl J Med. 2007;356:2343-2346. Abstract
Kraus JE, Horrigan JP, Carpenter DJ, Fong R, Barrett PS, Davies JT. Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy. J Affect Disord. 2010;120:40-47. Abstract
Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Mann JJ. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration Data Sets. Am J Psychiatry. 2007;164:1044-1049. Abstract
Gaynes BN, West SL, Ford CA, Frame P, Klein J, Lohr KN. Screening for suicide risk in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140:822-835. Abstract
Joe S, Woolley ME, Brown GK, Ghahramanlou-Holoway M, Beck AT. Psychometric properties of the Beck Depression Inventory-II in low-income, African American suicide attempters. J Pers Assess. 2008;90:521-523. Abstract
Lineham MM, Comtois KA, Brown MZ, Heard HL, Wagner A. Suicide Attempt Self-Injury Interview (SASII): development, reliability, and validity of a scale to assess suicide attempts and intentional self-injury. Psychol Assess. 2006;18:303-312. Abstract
Freedenthal S. Assessing the wish to die: a 30-year review of the suicide intent scale. Arch Suicide Res. 2008;12:277-298. Abstract
American Psychiatric Association. Practice Guideline for the Assessment and Treatment of Patients with Suicidal Behaviors. Am J Psychiatry. 2003;160(suppl 11):1-60.
McGuffin P, Marusic A, Farmer A. What can psychiatric genetics offer suicidology? Crisis. 2001;22:61-65.
Roy A, Nielsen D, Rylander G, et al. Genetics of suicide in depression. J Clin Psychiatry. 1999;60(suppl 2):12-17, discussion 18-20, 113-116.
Murphy GE, Wetzel RD, Robins E, et al. Multiple risk factors predict suicide in alcoholism. Arch Gen Psychiatry. 1992;49:459-463. Abstract
Brent DA, Perper JA, Allman CJ. Alcohol, firearms, and suicide among youth: temporal trends in Allegheny County, Pennsylvania, 1960 to 1983. JAMA. 1987;257:3369-3372. Abstract
Kim C, Lesage A, Seguin M, et al. Patterns of co-morbidity in male suicide completers. Psychol Med. 2003;33:1299-1309. Abstract
Trude S, Stoddard JJ. Referral gridlock: primary care physicians and mental health services. J Gen Intern Med. 2003;18:442-449.

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Author(s)

Bradley N. Gaynes, MD, MPH

Professor, Department of Psychiatry, University of North Carolina; Associate Chair of Research Training and Education, Chapel Hill, North Carolina

Disclosures

Disclosure: Bradley N. Gaynes, MD, MPH, has disclosed no relevant financial relationships.

Dr. Gaynes does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the US Food and Drug Administration (FDA) for use in the United States.

Dr. Gaynes does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

Jane Lowers

Scientific Director, Medscape LLC

Disclosures

Disclosure: Jane Lowers has disclosed no relevant financial relationships.

Writer(s)

Lynne K. Schneider, PhD

Freelance Medical Writer, Flanders, New Jersey

Disclosures

Disclosure: Lynne K. Schneider, PhD, has disclosed no relevant financial relationships.

Nurse Planner

Laurie E. Scudder, DNP, NP

Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC

Disclosures

Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.

CME Reviewer(s)

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

CME/CE

Screening and Treating for Suicide Risk in Patients With Depression

Authors: Bradley N. Gaynes, MD, MPH
CME/CE Released: 12/15/2010
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 12/15/2011, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This activity is intended for primary care physicians, physician assistants, nurse practitioners and nurses, and psychiatrists and psychiatry nurses involved in the treatment of patients with depression.

The goal of this activity is to outline the medical and legal responsibilities of physicians treating patients who may be at risk for suicide.

Upon completion of this activity, participants will be able to:

Identify risk factors associated with suicidality in the primary care population
Incorporate assessment for suicide risk into diagnosis and follow-up of patients with major depressive disorder
Formulate action plans for monitoring or treating patients with thoughts of suicide

Disclosures

Author(s)

Bradley N. Gaynes, MD, MPH

Professor, Department of Psychiatry, University of North Carolina; Associate Chair of Research Training and Education, Chapel Hill, North Carolina

Disclosures

Disclosure: Bradley N. Gaynes, MD, MPH, has disclosed no relevant financial relationships.

Dr. Gaynes does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the US Food and Drug Administration (FDA) for use in the United States.

Dr. Gaynes does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

Jane Lowers

Scientific Director, Medscape LLC

Disclosures

Disclosure: Jane Lowers has disclosed no relevant financial relationships.

Writer(s)

Lynne K. Schneider, PhD

Freelance Medical Writer, Flanders, New Jersey

Disclosures

Disclosure: Lynne K. Schneider, PhD, has disclosed no relevant financial relationships.

Nurse Planner

Laurie E. Scudder, DNP, NP

Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC

Disclosures

Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.

CME Reviewer(s)

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Accreditation Statements

For Physicians

Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Contact This Provider

For Nurses

Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

Accreditation of this program does not imply endorsement by either Medscape, LLC or ANCC.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape Education encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

processing....

The following test-and-teach case is an educational activity modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will be able to see whether you answered correctly and will then read evidence-based information that supports the most appropriate answer choice. Please note that these questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the case, there will be a short post-test assessment based on material covered in the activity.

Editor's note: This activity is part of a set of resources for Diagnosis and Treatment of Major Depressive Disorder: Performance Improvement, a Performance Improvement CME initiative on Medscape Education. PI CME offers physicians the opportunity to earn up to 20 AMA PRA Category 1 credits by evaluating their practice in a specific clinical area, identifying opportunities for improvement and implementing change, and measuring the results. The first step is a self-assessment. To learn more about PI CME, click here.

Case 1: Paula

Paula is a 42-year-old wife and mother of 2 preteen children. For the past 8 years, she has worked as a cashier at the local grocery store during the daytime while her children are in school. Paula has developed concerns over time about her ability to get moving in the morning and, after debating with herself for several weeks, makes an appointment with her clinician. During the consultation, she reports being tired all the time and feeling overwhelmed by her life. She thought at first that she might be sick, but it has been almost 2 months since she felt "herself." Paula also reports significant weight loss without dieting or exercise; when she recently put on her "nice outfit" to go out to dinner with her husband, she discovered that she had lost one or more dress sizes since she'd worn the outfit a few months earlier. Additionally, she admits she has trouble sleeping. "Sometimes I wish I would just go to sleep and not wake up," Paula states.

Page 1 of 10

CME/CE Information

Print
Like Tweet

References

Disclaimer

The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on www.medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

References

Faculty and Disclosures

Author(s)

Bradley N. Gaynes, MD, MPH

Editor(s)

Jane Lowers

Writer(s)

Lynne K. Schneider, PhD

Nurse Planner

Laurie E. Scudder, DNP, NP

CME Reviewer(s)

Nafeez Zawahir, MD

CME/CE

Screening and Treating for Suicide Risk in Patients With Depression

Target Audience and Goal Statement

Disclosures

Author(s)

Bradley N. Gaynes, MD, MPH

Editor(s)

Jane Lowers

Writer(s)

Lynne K. Schneider, PhD

Nurse Planner

Laurie E. Scudder, DNP, NP

CME Reviewer(s)

Nafeez Zawahir, MD

Accreditation Statements

For Physicians

For Nurses

Instructions for Participation and Credit

Screening and Treating for Suicide Risk in Patients With Depression

Case 1: Paula